Amount Raised
$31 Million
Round Type
Series B
St. PaulDescription
Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced that it has completed a $31 million Series B round of financing to fund its first clinical study in the United States. The financing was led by Xeraya Capital, a private equity and venture investor in life sciences that focuses on medical technologies, healthcare biotechnology, and bio-renewables. Also participating in the financing were Longview Ventures, Catalyst Health Ventures, BioStar Ventures, Cedar Point Capital, Frontcourt Group, and three strategic investors.
Who to call at Aria Cv, and when
A new round usually means Aria Cv is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aria Cv raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aria Cv, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aria Cv. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aria Cv raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAria Cv raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.